Senyo Health App - Connecting Primary Care to Substance Use Disorder Treatment Using a Telehealth Collaborative Care Platform
Sponsor: Mayo Clinic
Trial Details
| Condition | Substance Use Disorders, Substance Abuse |
| Intervention | Senyo App; Follow-up |
| Phase | NA |
| Status | Unknown |
| Participants | 60 |
| Est. Completion | 20 July 2027 |
| Last Updated | 22 May 2026 |
Primary Outcome
Brief Substance Craving Scale (BSCS); Timeline Follow Back
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Ability to read, write, and understand English * Minimum DAST (1+), audit-C score (3+) * Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care. * Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site; * Eligibility determined by ASAM Assessment Exclusion Criteria: * Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis * Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment * Needing a higher level of mental health care as demonstrated by ASAM32 assessment. * Decline to answer suicidality questions. * Already admitted into or about to initiate treatment in another addiction treatment program. Currently attending High School.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service